Jul 30, 2026 06:33AM
Jul 22, 2026 06:51AM
Jun 15, 2026 06:50AM
May 29, 2026 10:42AM
May 22, 2026 10:18AM
May 22, 2026 09:15AM
May 12, 2026 09:32AM Agios submits application for accelerated approval of mitapivat in sickle cell
Apr 29, 2026 06:30AM
Apr 21, 2026 08:48AM
Apr 21, 2026 06:41AM
Apr 20, 2026 10:14AM
Mar 31, 2026 01:08PM
Mar 31, 2026 09:48AM
Mar 31, 2026 08:54AM Stifel: 'we think FULC as a soon-to-be ph3 SCD company is significantly under-appreciated'
Mar 31, 2026 08:33AM
Mar 12, 2026 09:27AM
Mar 5, 2026 06:40AM
Feb 12, 2026 04:22PM
Feb 12, 2026 11:40AM
Jan 12, 2026 07:03AM
Dec 26, 2025 08:15AM Agios Pharma (AGIO) removed from Upside 30-Day Catalyst Watch at Citi
Dec 26, 2025 07:01AM
Dec 24, 2025 12:28PM
Dec 9, 2025 06:56AM
Dec 8, 2025 07:02AM
Nov 25, 2025 07:31AM
Nov 25, 2025 07:09AM
Nov 25, 2025 06:59AM Citi Starts Agios Pharma (AGIO) at Buy, PT $38
Nov 24, 2025 07:36AM
Nov 20, 2025 07:51AM
Nov 20, 2025 06:38AM
Nov 20, 2025 06:19AM
Nov 19, 2025 03:04PM
Nov 19, 2025 01:53PM
Nov 19, 2025 12:44PM RBC Capital Downgrades Agios Pharma (AGIO) to Sector Perform
Oct 30, 2025 06:30AM
Oct 20, 2025 06:42AM
Oct 17, 2025 08:15AM
Oct 17, 2025 08:01AM
Oct 16, 2025 04:45AM
Sep 24, 2025 03:10PM
Sep 5, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Agios Pharma (AGIO)
Sep 5, 2025 05:02AM
Sep 4, 2025 12:08PM
Sep 4, 2025 10:23AM
Sep 4, 2025 07:00AM
Aug 5, 2025 09:07AM
Aug 5, 2025 06:34AM
Aug 4, 2025 04:01PM Agios' PYRUKYND approved for thalassemia treatment in Saudi Arabia
Aug 4, 2025 01:59PM

445,877 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All